 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Nu Skin Enterprises, Inc. (NUS) develops and distributes personal care and wellness products worldwide.
It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
In addition, it is involved in the research and product development of skin care products and nutritional supplements.
Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website.
On November 4th, Nu Skin Enterprises reported 3rd Quarter September 2020 earnings of $1.08 per share on revenue of $703.3 million. The consensus earnings estimate was $0.99 per share on revenue of $676.3 million.
Share have since formed a bullish "flag" and are expected to move higher from this formation. The formation is supported by the stock's 50-day moving average.
Entry Point: $52.00
Stop Loss: $49.00
Trading Range: $12.31 - $57.01
Target Price: $57.20
NUS closed at $58.38
